Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

Industry Conversation with Kelsey Koenig

A documentary camera is the focal point beside a laptop showing an abstract virtual roundtable and a strip of film.

Industry Conversation with Kelsey Koenig: join VC Tuesday, June 9, 2026, 5pm ET for a returning Industry Conversations online roundtable linking VC Members and top professionals; Professional Development; location/city TBA; RSVP; not recorded to foster candor. Explore indie docs, equity financing, evolving distribution, impact-driven storytelling, and Impact Partners’ nonfiction support, plus Koenig’s role, filmmaker collaborations and career path; this intimate exchange fosters connections, insights and fewer barriers among video journalists, documentary filmmakers and industry leaders/decision makers. Koenig, Impact Partners’ VP of Production, has over a decade in indie docs; at the NYC fund backing docs on pressing social issues since 2012, she has helped finance/develop 100+ projects including SUGARCANE, APOCALYPSE IN THE TROPICS and MISTRESS DISPELLER, spoken worldwide on funding/distribution/impact panels, joined the PGA and earned DOC NYC’s 2023 Documentary New Leader honor.

Hosted with: Psychedelic Writers Guild